Prosthetic Joint Infections Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Prosthetic Joint Infections Treatment Market was valued at USD 95.59 Million in 2020 and is projected to reach USD 120.59 Million by 2028, expanding at a CAGR over 2% during the forecast period 2022-2028.

Artificial joint infection, also known as periprosthetic infection, is one of the most deadly infections affecting millions of people worldwide. Joint prosthesis infections usually include infections of adjacent tissues and joint prostheses. The majority of joint arthroplasty infections result from hip and knee arthroplasty. Artificial joint infection is one of the serious complications of joint arthroplasty, and the risk of infection at the surgical site is high. Treatment of artificial joint infection generally includes medical treatment and surgical intervention, including first-stage joint replacement, two-stage artificial joint replacement, antibacterial pmma spacer, antibacterial treatment through two-stage arthroplasty, arthroplasty without re-implantation, and amputation. Intervention is required.

Market Segments

By Type
• Fusidic acid
• Lefamulin Acetate
• MTF-101
• TNP-2092

By Application
• Hospital
• Clinic

Key Players

• CEMPRA INC
• MOTIF BIO PLC
• NABRIVA THERAPEUTICS AG
• TELEPHUS MEDICAL LLC
• TENNOR THERAPEUTICS LTD
• INOVIO PHARMACEUTICALS, INC.
• ONCBIOMUNE PHARMACEUTICALS INC.
• PULMAGEN THERAPEUTICS LLP

Scope of the Report

The research study analyzes the global Prosthetic Joint Infections Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Prosthetic Joint Infections Treatment Market Report

1. What was the Prosthetic Joint Infections Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Prosthetic Joint Infections Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Prosthetic Joint Infections Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.